π‘ Evidence suggests colloid/albumin replacement is not necessary to prevent haemodynamic deterioration after paracentesis.
β οΈ However, drain slowly β at most 4β6 L over β₯4 hours.
π About Ascites
- Malignant Ascites = accumulation of peritoneal fluid due to malignancy.
- Accounts for ~10% of all ascites cases.
- Common cancers: breast, colorectal, endometrial, gastric, ovarian, pancreatic.
𧬠Aetiology
- Peritoneal lymphatic obstruction (tumour spread).
- Low albumin β β oncotic pressure.
- β Capillary permeability (tumour inflammation).
- β Portal venous pressure β activation of RAA system.
π©Ί Clinical Presentation
- Abdominal bloating, distension, pain, nausea, vomiting.
- Other: anorexia, fatigue, peripheral oedema, reflux/heartburn, dyspnoea from raised diaphragm.
β οΈ Cautions for Paracentesis
- Coagulopathy: INR > 1.5, platelets < 40 Γ 10βΉ/L.
- Hyponatraemia < 126 mmol/L.
- Poor renal function, hepatic impairment.
- Severe anaemia, albumin < 20 g/L.
- Neutropenia / immunosuppression.
β Contraindications
- Local or systemic infection at drain site.
- Severe coagulopathy: platelets < 40 Γ 10βΉ/L or INR > 1.4.
- Limit drainage to 4β6 L max if: renal failure (Cr > 250), albumin < 30 g/L, Na < 125 mmol/L.
π¬ Investigations
- Bloods: FBC, U&Es, LFTs, clotting. Monitor U&Es daily if repeated paracentesis.
- Ascitic tap: send for MCS, SAAG (serumβascites albumin gradient), protein, glucose, LDH, cytology.
- Rule out SBP (spontaneous bacterial peritonitis) if fever or abdominal pain.
- β Avoid serum CA-125 (often falsely β in ascites).
π οΈ Management
- Poor prognosis β focus on comfort + quality of life (palliative intent).
- π Diuretics: Spironolactone 100β400 mg/day (slow onset ~5 days). Watch for nausea, hyperkalaemia, hyponatraemia.
- π Therapeutic paracentesis: Symptom relief with 4β6 L removed. Avoid excess drainage (hypovolaemia risk).
- π« Albumin infusion: Not required in malignant ascites (unlike cirrhotic ascites).
- Other options: peritoneovenous shunts in selected cases.
π References